We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
-17.24%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.28B
AUM Growth
-$359M
Cap. Flow
-$60.5M
Cap. Flow %
-4.73%
Top 10 Hldgs %
43.57%
Holding
141
New
3
Increased
11
Reduced
53
Closed
12

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$1.34M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$1.33M
3
PFE icon
Pfizer
PFE
+$762K
4
PYPL icon
PayPal
PYPL
+$467K
5
MEDP icon
Medpace
MEDP
+$463K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.62M
2
DKNG icon
DraftKings
DKNG
+$5.16M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.7M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.88M
5
EBAY icon
eBay
EBAY
+$3.76M

Sector Composition

Rank Sector Weight
1 Technology 41.48%
2 Healthcare 16.66%
3 Communication Services 14.06%
4 Consumer Discretionary 12.31%
5 Financials 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
51
UnitedHealth
UNH
$382B
$4.08M 0.32%
7,950
-1,300
-14% -$653K
UTHR icon
52
United Therapeutics
UTHR
$26.3B
$4.07M 0.32%
17,260
– –
IBM icon
53
IBM
IBM
$202B
$3.86M 0.3%
27,365
-181
-0.7% -$24.4K
PYPL icon
54
PayPal
PYPL
$49.5B
$3.69M 0.29%
52,873
+5,380
+11% +$467K
ELV icon
55
Elevance Health
ELV
$81.9B
$3.32M 0.26%
6,877
– –
CRUS icon
56
Cirrus Logic
CRUS
$6.74B
$3.31M 0.26%
45,563
– –
SIMO icon
57
Silicon Motion
SIMO
$9.19B
$3.29M 0.26%
39,269
– –
JAZZ icon
58
Jazz Pharmaceuticals
JAZZ
$15.9B
$3.24M 0.25%
20,777
+2,727
+15% +$420K
TMHC icon
59
Taylor Morrison
TMHC
$3.19M 0.25%
136,463
-28,941
-17% -$766K
KLIC icon
60
Kulicke & Soffa
KLIC
$5.3B
$3.03M 0.24%
70,838
– –
CI icon
61
Cigna
CI
$76.6B
$2.9M 0.23%
10,997
-1,495
-12% -$385K
AEIS icon
62
Advanced Energy
AEIS
$12.2B
$2.71M 0.21%
37,155
– –
JKHY icon
63
Jack Henry & Associates
JKHY
$10.7B
$2.69M 0.21%
14,925
-1,000
-6% -$187K
PEP icon
64
PepsiCo
PEP
$186B
$2.56M 0.2%
15,364
-50
-0.3% -$8.42K
SEDG icon
65
SolarEdge
SEDG
$2.59B
$2.44M 0.19%
8,897
-2,471
-22% -$676K
REGN icon
66
Regeneron Pharmaceuticals
REGN
$68.8B
$2.31M 0.18%
3,912
+337
+9% +$219K
NDSN icon
67
Nordson
NDSN
$16.5B
$2.3M 0.18%
11,354
– –
COHU icon
68
Cohu
COHU
$2.39B
$2.27M 0.18%
81,652
– –
CTXS
69
DELISTED
Citrix Systems Inc
CTXS
$2.23M 0.17%
22,990
– –
NXGN
70
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$2.19M 0.17%
125,660
– –
MRK icon
71
Merck
MRK
$324B
$2.17M 0.17%
23,750
-15
-0.1% -$1.33K
DIOD icon
72
Diodes
DIOD
$4B
$2.13M 0.17%
33,070
– –
CAH icon
73
Cardinal Health
CAH
$53.4B
$2.12M 0.17%
40,540
– –
EXEL icon
74
Exelixis
EXEL
$13.9B
$2.07M 0.16%
99,343
– –
TMO icon
75
Thermo Fisher Scientific
TMO
$211B
$2.01M 0.16%
3,703
– –
1 2
3
4 5

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Oak Associates held 141 positions worth $1.28B, down 22% from $1.64B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Oak Associates withdrew a net $60.5M in Q2 2022, closing 12 positions and reducing 53 holdings. Its most notable exit was DraftKings, an estimated $5.16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Oak Associates opened a new position in Moderna worth $1.34M.

  • Oak Associates's largest Q2 2022 buy was Moderna: 9,393 shares worth $1.34M.
  • Oak Associates added most to Pfizer in Q2 2022, an estimated $762K increase.
  • Oak Associates's biggest Q2 2022 reduction was Apple, cutting an estimated $7.62M.
  • Oak Associates fully exited DraftKings in Q2 2022, selling an estimated $5.16M.
  • Oak Associates's ten largest holdings make up 44% of its $1.28B portfolio in Q2 2022.
  • Oak Associates opened 3 new positions and closed 12 in Q2 2022.
  • Oak Associates's portfolio value fell 22% quarter-over-quarter to $1.28B.

Based on Oak Associates's 13F filing for Q2 2022, filed 12 Aug 2022.